Cargando…

Proteolysis and antigen presentation by MHC class II molecules

Proteolysis is the primary mechanism used by all cells not only to dispose of unwanted proteins but also to regulate protein function and maintain cellular homeostasis. Proteases that reside in the endocytic pathway are the principal actors of terminal protein degradation. The proteases contained in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bryant, Paula Wolf, Lennon-Duménil, Ana-Maria, Fiebiger, Edda, Lagaudriére-Gesbert, Cécile, Ploegh, Hidde L
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2002
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7130937/ https://www.ncbi.nlm.nih.gov/pubmed/12078484 http://dx.doi.org/10.1016/S0065-2776(02)80013-X

Ejemplares similares

Analysis of Protease Activity in Live Antigen-presenting Cells Shows Regulation of the Phagosomal Proteolytic Contents During Dendritic Cell Activation
por: Lennon-Duménil, Ana-Maria, et al.
Publicado: (2002)

Cathepsin S Controls the Trafficking and Maturation of Mhc Class II Molecules in Dendritic Cells
por: Driessen, Christoph, et al.
Publicado: (1999)

Cytokines Regulate Proteolysis in Major Histocompatibility Complex Class II–Dependent Antigen Presentation by Dendritic Cells
por: Fiebiger, Edda, et al.
Publicado: (2001)

Class II MHC Self-Antigen Presentation in Human B and T Lymphocytes
por: Costantino, Cristina Maria, et al.
Publicado: (2012)

Early BCR Events and Antigen Capture, Processing, and Loading on MHC Class II on B Cells
por: Avalos, Ana M., et al.
Publicado: (2014)

Ubiquitin-Dependent Control of Class II MHC Localization Is Dispensable for Antigen Presentation and Antibody Production
por: McGehee, Annette M., et al.
Publicado: (2011)

Invariant Chain Controls the Activity of Extracellular Cathepsin L
por: Fiebiger, Edda, et al.
Publicado: (2002)

Intermediates in the Assembly and Degradation of Class I Major Histocompatibility Complex (MHC) Molecules Probed with Free Heavy Chain–specific Monoclonal Antibodies
por: Machold, Robert P., et al.
Publicado: (1996)

Targeted antigen delivery by an anti-class II MHC VHH elicits focused αMUC1(Tn) immunity
por: Fang, Tao, et al.
Publicado: (2017)

Superantigen and class II MHC molecules.
por: Kim, J.
Publicado: (1995)

The actin-based motor protein myosin II regulates MHC class II trafficking and BCR-driven antigen presentation
por: Vascotto, Fulvia, et al.
Publicado: (2007)

MHC class II-derived peptides can bind to class II molecules, including self molecules, and prevent antigen presentation
Publicado: (1990)

Abrogation of self-tolerance by misfolded self-antigens complexed with MHC class II molecules
por: Jin, Hui, et al.
Publicado: (2022)

Cotranslational endoplasmic reticulum assembly of FcɛRI controls the formation of functional IgE-binding receptors
por: Fiebiger, Edda, et al.
Publicado: (2005)

Isoforms of the invariant chain regulate transport of MHC class II molecules to antigen processing compartments
Publicado: (1996)

MHC Class II Auto-Antigen Presentation is Unconventional
por: Sadegh-Nasseri, Scheherazade, et al.
Publicado: (2015)

Presentation of Exogenous Antigens on Major Histocompatibility Complex (MHC) Class I and MHC Class II Molecules Is Differentially Regulated during Dendritic Cell Maturation
por: Delamarre, Lélia, et al.
Publicado: (2003)

The Pathway of Us11-Dependent Degradation of Mhc Class I Heavy Chains Involves a Ubiquitin-Conjugated Intermediate
por: Shamu, Caroline E., et al.
Publicado: (1999)

Negri bodies and other virus membrane-less replication compartments()
por: Nevers, Quentin, et al.
Publicado: (2020)

Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation
por: Wieczorek, Marek, et al.
Publicado: (2017)

Screen for ISG15-crossreactive Deubiquitinases
por: Catic, André, et al.
Publicado: (2007)

Expression of MHC Class II Antigens During Xenopus Development
por: Du Pasquier, Louis, et al.
Publicado: (1990)

Antigen Processing for MHC Class II Presentation via Autophagy
por: Münz, Christian
Publicado: (2012)

Induction of tolerance against the arthritogenic antigen with type-II collagen peptide-linked soluble MHC class II molecules
por: Park, Yoon-Kyung, et al.
Publicado: (2016)

Rabies Virus Infection Induces the Formation of Stress Granules Closely Connected to the Viral Factories
por: Nikolic, Jovan, et al.
Publicado: (2016)

MHC class II molecules on pancreatic cancer cells indicate a potential for neo-antigen-based immunotherapy
por: Baleeiro, Renato B., et al.
Publicado: (2022)

MHC Class II and Non-MHC Class II Genes Differentially Influence Humoral Immunity to Bacillus anthracis Lethal Factor and Protective Antigen
por: Garman, Lori, et al.
Publicado: (2012)

Immunological Functions of the Membrane Proximal Region of MHC Class II Molecules
por: Harton, Jonathan, et al.
Publicado: (2016)

A Missing Switch in Peptide Exchange for MHC Class II Molecules
por: Freund, Christian, et al.
Publicado: (2019)

HLA-DO and Its Role in MHC Class II Antigen Presentation
por: Poluektov, Yuri O., et al.
Publicado: (2013)

Targeting the MHC Class II antigen presentation pathway in cancer immunotherapy
por: Thibodeau, Jacques, et al.
Publicado: (2012)

Angiotensin converting enzyme affects the presentation of MHC class II antigens
por: Zhao, Tuantuan, et al.
Publicado: (2017)

Influence of DM-sensitivity on immunogenicity of MHC class II restricted antigens
por: Bernhardt, Anna Luise, et al.
Publicado: (2021)

Trophoblast Class I Major Histocompatibility Complex (MHC) Products Are Resistant to Rapid Degradation Imposed by the Human Cytomegalovirus (HCMV) Gene Products US2 and US11
por: Schust, Danny J., et al.
Publicado: (1998)

Structural Properties of MHC Class II Ligands, Implications for the Prediction of MHC Class II Epitopes
por: Jørgensen, Kasper Winther, et al.
Publicado: (2010)

Neoleukin-2 enhances anti-tumour immunity downstream of peptide vaccination targeted by an anti-MHC class II VHH
por: Crowley, Stephanie J., et al.
Publicado: (2020)

Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
por: Korkolopoulou, P., et al.
Publicado: (1996)

Peptide length significantly influences in vitro affinity for MHC class II molecules
por: O'Brien, Cathal, et al.
Publicado: (2008)

Characterization of Structural Features Controlling the Receptiveness of Empty Class II MHC Molecules
por: Rupp, Bernd, et al.
Publicado: (2011)

Limitations of Ab Initio Predictions of Peptide Binding to MHC Class II Molecules
por: Zhang, Hao, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_dbip19rah8vi9t0qb1o93vqllq